» Articles » PMID: 18588539

Protein Degradation, As with Protein Synthesis, is Required During Not Only Long-term Spatial Memory Consolidation but Also Reconsolidation

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2008 Jul 1
PMID 18588539
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The formation of long-term memory requires protein synthesis, particularly during initial memory consolidation. This process also seems to be dependant upon protein degradation, particularly degradation by the ubiquitin-proteasome system. The aim of this study was to investigate the temporal requirement of protein synthesis and degradation during the initial consolidation of allocentric spatial learning. As memory returns to a labile state during reactivation, we also focus on the role of protein synthesis and degradation during memory reconsolidation of this spatial learning. Male CD1 mice were submitted to massed training in the spatial version of the Morris water maze. At various time intervals after initial acquisition or after a reactivation trial taking place 24 h after acquisition, mice received an injection of either the protein synthesis inhibitor anisomycin or the protein degradation inhibitor lactacystin. This injection was performed into the hippocampal CA3 region, which is specifically implicated in the processing of spatial information. Results show that, in the CA3 hippocampal region, consolidation of an allocentric spatial learning task requires two waves of protein synthesis taking place immediately and 4 h after acquisition, whereas reconsolidation requires only the first wave. However, for protein degradation, both consolidation and reconsolidation require only one wave, taking place immediately after acquisition or reactivation, respectively. These findings suggest that protein degradation is a key step for memory reconsolidation, as for consolidation. Moreover, as protein synthesis-dependent reconsolidation occurred faster than consolidation, reconsolidation did not consist of a simple repetition of the initial consolidation.

Citing Articles

Proteasome Augmentation Mitigates Age-Related Cognitive Decline in Mice.

Parker D, Davidson K, Osmulski P, Gaczynska M, Pickering A Aging Cell. 2025; 24(3):e14492.

PMID: 39945352 PMC: 11896255. DOI: 10.1111/acel.14492.


Involvement of ubiquitination in Alzheimer's disease.

Lin N, Gao X, Li X, Chu W Front Neurol. 2024; 15:1459678.

PMID: 39301473 PMC: 11412110. DOI: 10.3389/fneur.2024.1459678.


Synaptic proteasome is inhibited in Alzheimer's disease models and associates with memory impairment in mice.

Ribeiro F, Cozachenco D, Heimfarth L, Fortuna J, de Freitas G, de Sousa J Commun Biol. 2023; 6(1):1127.

PMID: 37935829 PMC: 10630330. DOI: 10.1038/s42003-023-05511-9.


The ubiquitin-proteasome system and learning-dependent synaptic plasticity - A 10 year update.

Patrick M, Omar N, Werner C, Mitra S, Jarome T Neurosci Biobehav Rev. 2023; 152:105280.

PMID: 37315660 PMC: 11323321. DOI: 10.1016/j.neubiorev.2023.105280.


The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease.

Davidson K, Pickering A Front Cell Dev Biol. 2023; 11:1124907.

PMID: 37123415 PMC: 10133520. DOI: 10.3389/fcell.2023.1124907.